Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
ZyGEM and Lockheed Martin Announce Early Release for Rapid DNA Platform
Thursday, May 31, 2012
Companies unveil key component at leading forensics science meeting.

Bio-Rad Introduces First ProteOn™ Sensor Chip
Thursday, May 24, 2012
Product capable of label-free interaction analysis of membrane proteins with peptides and small molecules.

MPI Research Invests in an Additional Gyrolab™ xP Workstation
Wednesday, May 23, 2012
Gyros’ nanoliter-scale immunoassay platform proves commercial success for US-based CRO.

Dolomite Develops Novel Droplet System
Monday, May 21, 2012
New system for the encapsulation of single cells or beads into droplets.

Rubicon Launches Simplest, Fastest, Most Sensitive Sample Prep for NGS
Thursday, May 17, 2012
First product ThruPLEX-FD for fragmented DNA delivers highly sensitive and consistent results from range of sample types in just 2 hours.

IBN's Droplet Array Sheds Light on Drug-Resistant Cancer Stem Cells
Wednesday, May 09, 2012
Cheaper, faster and convenient drug screening using limited samples.

Artel Highlights New Uses of the MVS to Improve Assay Performance
Wednesday, April 25, 2012
Two new applications that use the Artel MVS® Multichannel Verification System verify key steps in the assay workflow

Introducing EXP Nano Fittings for UHPLC
Monday, April 23, 2012
Optimize Technologies announced the expansion of the EXP Fitting System to include EXP Nano Fittings.

SAW Instruments Launches sam®X Biosensor Access Program
Wednesday, April 11, 2012
Lease the high-end sam®X for six months with no capital spend.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1046
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed